Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dongkoo BIO & Pharma CO.
AddedFeb 15, 2024
UpdatedJun 28, 2026
Dongkoo BIO & Pharma CO.

Dongkoo BIO & Pharma CO.

Public

Dongkoo Bio & Pharma: A pharmaceutical company specializing in probiotics, gum disease solutions, and health foods.

HQ
Seoul, Seoul, KR
Founded
1993
Overview
Compare
Employees
Website

Dongkoo Bio & Pharma Co., Ltd. is a pharmaceutical company dedicated to improving health and well-being through innovative products. Specializing in probiotics, gum disease solutions, and health functional foods, the company aims to lead in total healthcare. Their mission focuses on advancing human health and welfare through continuous research and development.

Dongkoo Bio & Pharma has achieved significant recognition as a top dermatology prescription provider. Their commitment to technology and innovation has positioned them as a trusted leader in the pharmaceutical industry, contributing to healthier and happier lives.

Dongkoo BIO & Pharma CO. - Similar Companies

Daewoong Pharmaceutical Co. logo

Daewoong Pharmaceutical Co.

daewoong.co.kr

Dong-A ST Co. logo

Dong-A ST Co.

Kukje Pharma Co. logo

Kukje Pharma Co.

Bukwang Pharmaceutical logo

Bukwang Pharmaceutical

bukwang.co.kr

Genome & Co logo

Genome & Co

Boryung logo

Boryung

boryung.co.kr

Hanall Biopharma Co. logo

Hanall Biopharma Co.

Yantai Dongcheng Pharmaceutical Co logo

Yantai Dongcheng Pharmaceutical Co

dcb-group.com

pH Pharma logo

pH Pharma

ph-pharma.com

Green Cross logo

Green Cross

Hanmi Pharmaceutical Co. logo

Hanmi Pharmaceutical Co.

Sino Biopharmaceutical logo

Sino Biopharmaceutical

SK Bioscience logo

SK Bioscience

skbioscience.co.kr

BodyBio logo

BodyBio

bodybio.co.uk

D&D Pharmatech logo

D&D Pharmatech

Dongkoo BIO & Pharma CO. - Quick Facts

Who are Dongkoo BIO & Pharma CO.'s competitors?

Companies similar to Dongkoo BIO & Pharma CO. include Daewoong Pharmaceutical Co., Dong-A ST Co., Kukje Pharma Co. and Bukwang Pharmaceutical.

When was Dongkoo BIO & Pharma CO. founded?

Dongkoo BIO & Pharma CO. was founded in 1993.

Where is Dongkoo BIO & Pharma CO.'s headquarters located?

Dongkoo BIO & Pharma CO.'s headquarters is located in Seoul, Seoul, KR.

How many employees does Dongkoo BIO & Pharma CO. have?

Dongkoo BIO & Pharma CO. has 292 employees as of Feb 4, 2024.

Dongkoo BIO & Pharma CO. - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Pharmaceuticals
  • Probiotics
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations